Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Merck & Co Stock (NYSE: MRK) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 3.13K / 9.98M |
Day Range | - - - |
52 Wk Range | 99.14 - 134.63 |
Market Cap | $293.51B |
P/E Ratio | 21.41 |
Dividend Yield | 2.66% |
Exchange | NYSE |
RSI | 45 |
Short Interest | 1.02% |
Days to Cover | 3.57 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Merck & Co (NYSE:MRK) through any online brokerage.
Other companies in Merck & Co’s space includes: Novo Nordisk (NYSE:NVO), Johnson & Johnson (NYSE:JNJ), Novartis (NYSE:NVS), Pfizer (NYSE:PFE) and Axsome Therapeutics (NASDAQ:AXSM).
Merck & Co has a consensus price target of $127.68.
The stock price for Merck & Co (NYSE: MRK) is $115.79 last updated September 24, 2024 at 6:16 AM EDT.
A quarterly cash dividend of 0.77 per share of Class A Common Stock. The quarterly cash dividend was payable on October 7, 2024 to stockholders of record on September 16, 2024.
Merck & Co’s Q3 earnings are confirmed for Thursday, October 31, 2024.
There is no upcoming split for Merck & Co.
Merck & Co is in the Health Care sector and Pharmaceuticals industry. They are listed on the NYSE.